Spinal effects of chronic intrathecal administration of the thyrotrophin-releasing hormone analogue (CG 3509) in rats

Brain Res. 1988 Jul 5;455(1):157-61. doi: 10.1016/0006-8993(88)90126-6.

Abstract

The effect of repeated intrathecal administration of a thyrotrophin-releasing hormone (TRH) analogue (CG 3509; 2 micrograms twice daily for 5 days) on wet-dog shake (WDS) and forepaw-licking (FPL) behaviours and spinal cord TRH and indoleamine levels and choline acetyltransferase (ChAT) activity was examined in adult rats. A rapid behavioural tolerance developed to repeated intrathecal injections of CG 3509; WDS and FPL behaviours were reduced by 57% and 34%, respectively, following the fifth injection and remained reduced at the ninth injection. Repeated CG 3509 administration selectively elevated ChAT activity and the level of 5-hydroxytryptamine (5-HT) in the ventral but not in the dorsal horn of the spinal cord, while 5-hydroxyindoleacetic acid (5-HIAA) and TRH levels were unaltered in either region. As ventral horn ChAT activity is principally located within motoneurones this data implies that TRH exerts a trophic-like influence on mature rat motoneurones in vivo. The results also suggest that long-term intrathecal TRH administration may decrease the release of 5-HT from bulbospinal raphe neurones.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Choline O-Acetyltransferase / metabolism
  • Hydroxyindoleacetic Acid / metabolism
  • Injections, Spinal
  • Male
  • Rats
  • Rats, Inbred Strains
  • Reference Values
  • Serotonin / metabolism
  • Spinal Cord / drug effects
  • Spinal Cord / physiology*
  • Stereotyped Behavior / drug effects
  • Thyrotropin-Releasing Hormone / administration & dosage
  • Thyrotropin-Releasing Hormone / analogs & derivatives*
  • Thyrotropin-Releasing Hormone / metabolism
  • Thyrotropin-Releasing Hormone / pharmacology

Substances

  • orotirelin
  • Serotonin
  • Hydroxyindoleacetic Acid
  • Thyrotropin-Releasing Hormone
  • Choline O-Acetyltransferase